Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Silymarin
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Phase IV
Sponsor : Fiterman Pharma SRL
Deal Size : Inapplicable
Deal Type : Inapplicable
Complex Imaging Assessment of Steatosis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
February 01, 2016
Lead Product(s) : Silymarin
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Phase IV
Sponsor : Fiterman Pharma SRL
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Silymarin
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Phase II
Sponsor : Rottapharm Biotech
Deal Size : Inapplicable
Deal Type : Inapplicable
Silymarin for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 10, 2013
Lead Product(s) : Silymarin
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Phase II
Sponsor : Rottapharm Biotech
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Silymarin
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II/ Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Legalon
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 07, 2013
Lead Product(s) : Silymarin
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II/ Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Silymarin
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Legalon SIL for the Treatment of HCV Recurrence in Liver Transplanted Patients
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 17, 2012
Lead Product(s) : Silymarin
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Silymarin
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Azienda Ospedaliera Universitaria Policlinico
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of LEGALON SIL on Hepatitis C Virus Recurrence in Stable Liver Transplanted Patients
Details : Undisclosed
Product Name : Legalon
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 26, 2012
Lead Product(s) : Silymarin
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Azienda Ospedaliera Universitaria Policlinico
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Silymarin
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 13, 2010
Lead Product(s) : Silymarin
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable